Should we invariably follow the current guidelines to treat our HCC patients?

Hepatobiliary Pancreat Dis Int. 2019 Jun;18(3):301-302. doi: 10.1016/j.hbpd.2019.01.005. Epub 2019 Jan 21.

Authors

Wen-Tao Yan¹, Bing Quan¹, Jiong-Jie Yu¹, Tian Yang²

Affiliations

¹ Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China; Department of Clinical Medicine, Second Military Medical University, Shanghai 200433, China.
² Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, Second Military Medical University, Shanghai 200438, China. Electronic address: [email protected].

PMID: 30686653
DOI: 10.1016/j.hbpd.2019.01.005

No abstract available

Publication types

Letter
Comment

MeSH terms

Carcinoma, Hepatocellular*
Cohort Studies
Evidence-Based Medicine
Humans
Liver Neoplasms*